After a federal court on July 8 blocked a Trump administration rule — a day before it was set to take effect — requiring pharmaceutical manufacturers to disclose prescription drugs’ list prices in direct-to-consumer (DTC) television ads, HHS brushed aside the legal setback for its high-profile initiative as “disappointing.” The judge indicated that Congress would need to act on the matter, and on July 10 two senators said they intend to plow ahead and do just that.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.